ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2723 • 2013 ACR/ARHP Annual Meeting

    Role Of Interferon-Inducible RNA-Dependent Protein Kinase In The Pathogenesis Of Systemic Lupus Erythematosus

    Aurélie De Groof1, Benoît Van den Eynde2, Frédéric A. Houssiau3 and Bernard Lauwerys1, 1Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 2Institut de Duve, Université catholique de Louvain, Brussels, Belgium, 3Institut de Recherche Expérimentale et Clinique, Pôle de Maladies Rhumatismales, Université catholique de Louvain, Brussels, Belgium

    Background/Purpose: PRKR (interferon-inducible RNA-dependent protein kinase) is an intracytoplasmic molecule that induces the production of interferon(IFN)-induced genes upon binding of double-stranded RNA viruses. PRKR is…
  • Abstract Number: 2724 • 2013 ACR/ARHP Annual Meeting

    cAMP Responsive Element Modulator (CREM)α Governs CD8 Expression and Contributes to the Generation of CD3+CD4–CD8– T Cells in Lupus

    Christian M. Hedrich1, José C. Crispín1, Thomas Rauen1, Christina Ioannidis1, Tomohiro Koga2, Noe Rodriguez Rodriguez2, Sokratis A. Apostolidis3, Vasileios C. Kyttaris2 and George C. Tsokos1, 1Medicine/Rheumatology, BIDMC, Harvard Medical School, Boston, MA, 2Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: CD3+CD4-CD8- "double negative" T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus (SLE) and lupus-prone mice. Double negative T…
  • Abstract Number: 2725 • 2013 ACR/ARHP Annual Meeting

    Regulation Of Aberrant CD4 T Cell Activation By Suppressor Of Cytokine Signaling-1 (SOCS1) Mimetic Peptide, Has Relevance To Human Systemic Lupus Erythematosus

    Tenisha Wilson1, Cristina Armbruster2, Simone Bedoya2, Howard M. Johnson2, Westley H. Reeves3, Yi Li4, Ying Yi Zheng5, Laurence Morel6 and Joseph Larkin III2, 1Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL, 2Microbiology and Cell Science, University of Florida, Gainesville, FL, 3Rheumatology & Clinical Imm, University of Florida, Gainesville, FL, 4Medicine, University of Florida, Gainesville, FL, 5Pathology, University of Florida, Gainesville, FL, 6Pathology/Immunology/Lab Medical, University of Florida, Gainesville, FL

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease, mediated by aberrantly activated CD4 T cells.  Notably, suppressor of cytokine signaling-1 (SOCS1) regulates CD4 T…
  • Abstract Number: 2727 • 2013 ACR/ARHP Annual Meeting

    Immunologic and Inflammatory Markers Of Impending Disease Flare In Systemic Lupus Erythematosus Patients Not Taking Immunosuppressive Medications In The Biomarkers Of Lupus Disease (BOLD) Study

    Joel M. Guthridge1, Mikhail G. Dozmorov2, Melissa E. Munroe3, Krista M. Bean1, Sudhakar T. Sridharan4, Joan T. Merrill5 and Judith A. James6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clincial Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4BioTherapeutics R&D, Pfizer Inc, Collegeville, PA, 5Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Clinical Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is a clinically heterogeneous disorder characterized by a waxing and waning clinical course. Predictors of clinical disease flare have been…
  • Abstract Number: 2728 • 2013 ACR/ARHP Annual Meeting

    The Small Ubiquitin Related Modifier-1 (SUMO-1) Regulates Osteoclast Differentiation In Vitro and In Vivo.

    Svetlana Frank1, Daniel Umlauf2, Olli A. Jänne3 and Thomas Pap4, 1Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Muenster, Germany, 2Institute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 3Univ Helsinki, Inst Biomed Physiol, Biomedicum, Helsinki, Finland, 4Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: Posttranslational modification of proteins by SUMO has been shown for a number of target molecules including transcription factors and is involved in a variety…
  • Abstract Number: 2729 • 2013 ACR/ARHP Annual Meeting

    Identification Of Osteoarthritis Patients With Chronic Inflammation Driven Disease Progression

    Anne Sofie Siebuhr1, Kristian Kjaer Petersen2, Lars Arendt-Nielsen3, Line Egsgaard2, Thomas Navndrup Eskehave4, Ole Simonsen5, Claus Christiansen4,6, Hans Christian Hoeck4, Morten Asser Karsdal7 and Anne C. Bay-Jensen8, 1Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 2Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Denmark, Center for Sensory-Motor Interaction, Aalborg, Denmark, 3Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Center for Sensory-Motor Interaction, Aalborg, Denmark, 4Center for Clinical and Basic Research and C4Pain, Aalborg, Denmark, 5Frederikshavn Hospital, Frederikshavn, Denmark, 6Nordic Bioscience, Herlev, Denmark, 7Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 8Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

    Background/Purpose: In osteoarthritis (OA) it is evident that a subset of patients experiences chronic tissue inflammation and may benefit from anti-inflammatory treatment. The systemic inflammation…
  • Abstract Number: 2730 • 2013 ACR/ARHP Annual Meeting

    Netrin1 Is a Critical Autocrine Factor For Osteoclast Differentiation

    Aranzazu Mediero1, Bhama Ramkhelawon2, Kathryn Moore2, P. Edward Purdue3, Steven R. Goldring4 and Bruce N. Cronstein5, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Leon H. Charney Division of Cardiology, Department of Medicine,, NYU School of Medicine, New York, NY, 3Research, Hospital for Special Surgery, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Internal Medicine, NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Netrins have been extensively studied for their role in axonal guidance during neural development. In addition, netrins are chemopulsants for a variety of non-neuronal…
  • Abstract Number: 2731 • 2013 ACR/ARHP Annual Meeting

    An Acetyl-Histone Mimetic Blocks Proinflammatory Activation Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    P. A. Kabala1, A.M. Grabiec1, C. Angiolilli1, Nicholas Smithers2, Jason Witherington3, Paul Peter Tak4, Rabinder Prinjha3 and Kris A. Reedquist5, 1Department of Experimental Immunology, Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Immuno Inflammation, GlaxoSmithKline, Stevenage, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4Academic Medical Center / University of Amsterdam, Department of Clinical Immunology and Rheumatology & GlaxoSmithKline, Amsterdam, Netherlands, 5Department of Experimental Immunology and Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Genetic backgrounds and environmental factors do not completely explain the etiology of disease and predisposition to rheumatoid arthritis (RA), and increasing attention has turned…
  • Abstract Number: 2732 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of Autophagy Prevents Ovariectomy Induced Bone Loss

    Neng-Yu Lin1, Joerg H. W. Distler1, Alfiya Distler1, Christian Beyer1, Georg Schett2 and Oliver Distler3, 1Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 3Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Autophagy is an essential, homeostatic process by which cells digest unnecessary or damaged organelles. Atg7 is essentially required for formation of the autophagosome. The…
  • Abstract Number: 2733 • 2013 ACR/ARHP Annual Meeting

    Spontaneous Osteoarthritis In Mice By Genetic Deletion Of Nfatc1 and Nfatc2

    Susan Y. Ritter1, Matthew B. Greenblatt2, Kelly Tsang1, Dorothy Z. Hu3, John Wright4 and Antonios O. Aliprantis1, 1Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Pathology, Brigham and Women's Hospital, Boston, MA, 3Endocrine Unit, Massachusetts General Hospital, Boston, MA, 4Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Osteoarthritis (OA) was once viewed as a mechanical disease of “wear and tear”, but recent advances suggest that OA results from active dysregulation of…
  • Abstract Number: 2734 • 2013 ACR/ARHP Annual Meeting

    Epigenetic Control Of a Gene Regulatory Network Associated With Experimental Autoimmune Arthritis and Rheumatoid Arthritis

    Andras Vida1, Janos Gal2, Gyorgyi Soos2, Attila Balog3, Laszlo G. Puskas4, Katalin Mikecz1, Tibor T. Glant1 and Tibor A. Rauch1, 1Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 2Rheumatology, Bacs-Kiskun County Hospital, Kecskemet, Hungary, 3Rheumatology, Albert Szent-Gyorgyi University, Szeged, Hungary, 4Laboratory of Functional Genomics, Biological Research Center, Szeged, Hungary

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder that mainly affects the synovial joints, leading to destruction of articular cartilage and bone. There is…
  • Abstract Number: 2735 • 2013 ACR/ARHP Annual Meeting

    Integrative Analysis Of Multiple Omics Technologies Reveals a Novel Therapeutic Target For Rheumatoid Arthritis (RA)

    David L. Boyle1, John Whitaker2, Beatrix Bartok3, Wei Wang4 and Gary S. Firestein5, 1Div of Rheum, UCSD School of Medicine, La Jolla, CA, 2Chemistry, UCSD School of Medicine, La Jolla, CA, 3Rheumatology, UCSD School of Medicine, La Jolla, CA, 4Chemistry, UCSD, La Jolla, CA, 5Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

    Background/Purpose:   Identifying novel therapeutic targets for immune-mediated disease has become increasingly challenging. We used an unbiased method to integrate multiple “omics” methodologies and evaluate…
  • Abstract Number: 2700 • 2013 ACR/ARHP Annual Meeting

    Abnormal Mitochondrial Electron Transport Chain Activity At Complex I Is Regulated By Nitric Oxide and N-Acetylcysteine In Lupus Lymphocytes

    Edward Doherty1 and Andras Perl2, 1Immunology, SUNY Upstate, Syracuse, NY, 2Dept of Medicine, SUNY Upstate Medical University, Syracuse, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) peripheral blood lymphocytes (PBL) show mitochondrial dysfunction, characterized by elevated mitochondrial transmembrane potential (Δψm) and mass and low ATP, attributed…
  • Abstract Number: 2695 • 2013 ACR/ARHP Annual Meeting

    Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger

    Linda Rehaume1, Stanislas Mondot2, Daniel Aguirre de Cárcer2, Jared Velasco1, Helen Benham1, Sumaira Hasnain3, Jaclyn Bowman1, Merja Ruutu1, Philip Hansbro4, Michael McGuckin3, Mark Morrison2 and Ranjeny Thomas1, 1University of Queensland Diamantina Institute, Brisbane, Australia, 2CSIRO Livestock Industries, Brisbane, Australia, 3Mater Medical Research Institute, Brisbane, Australia, 4Center for Asthma and Respiratory Disease and Hunter Medical Research Institute, Newcastle, Australia

    Background/Purpose: Chronic inflammatory diseases known as spondyloarthropathies (SpA) including ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and arthritis associated with inflammatory bowel disease, collectively affect 3%…
  • Abstract Number: 2696 • 2013 ACR/ARHP Annual Meeting

    Impaired Bacterial Clearance and An Exuberant Inflammatory Response Promote Chlamydia-Induced Reactive Arthritis In SKG Mice

    Athan Baillet1, Linda Rehaume2, Helen Benham2, Connor O'Meara3, Charles Armitage4, Marina Harvie4, Geraldine Brizard5, Jared Velasco2, John V. Forrester6, Mariapia Degli-Esposti5, Kenneth Beagley4 and Ranjeny Thomas2, 1Diamantina Institute, The University of Queensland, Brisbane, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, 3Institute of Health & Biomedical Innovation, Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia, 4Institute of Health & Biomedical Innovation, Brisbane, Australia, 5Lions Eye Institute, Nedlands, Australia, 6Lions Eye Institute, Nedlands, Bahrain

    Background/Purpose:  The sterile inflammatory arthritis associated with spondylitis, uveitis and rash, known as reactive arthritis, commences weeks after certain gastrointestinal or genitourinary infections, including Salmonella…
  • « Previous Page
  • 1
  • …
  • 2250
  • 2251
  • 2252
  • 2253
  • 2254
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology